Dr. Angel Treasa Alex is an Associate Professor in the Department of Pharmaceutical Biotechnology at Manipal College of Pharmaceutical Sciences (MCOPS), Manipal Academy of Higher Education (MAHE), Manipal. With a Ph.D. and M.Pharm in Pharmaceutical Biotechnology, her academic journey has been marked by commitment to research and teaching excellence. Her research primarily focuses on NDDS, especially nanoparticle and liposome-based formulations targeting cancer and CNS disorders. She has contributed extensively to areas such as siRNA therapeutics and cancer. Dr. Alex teaches undergraduate and postgraduate courses in pharmaceutical biotechnology and has guided several postgraduate and Ph.D. students and has published widely in reputed journals. With h index 14, Dr Alex is a recipient of prestigious Dr TMA Pai Gold Medal for outstanding research at MCOPS, the Good Teacher Award twice, and other professional honors. She serves on editorial boards and institutional committees, contributing to academic and scientific advancement within the field.

Dr. Mohammad H. Alyami is an Associate Professor of Pharmaceutics at the College of Pharmacy, Najran University, Saudi Arabia, specializing in drug delivery systems and pharmaceutical formulations. He earned his PhD in Pharmaceutical Sciences from Aston University, UK, and has over a decade of academic and research experience in pharmaceutics, nanomedicine, and innovative drug delivery technologies. His work focuses on developing advanced formulations, including nanoparticles, lipid-based systems, and inhalable therapeutics, aimed at improving drug solubility, bioavailability, and targeted delivery. Dr. Alyami has published extensively in high-impact journals and has actively collaborated with international researchers and institutions, contributing to the advancement of pharmaceutical sciences. He regularly participates in global conferences, presenting his research and engaging in academic exchange. Beyond research, he is committed to mentoring pharmacy students, supervising research projects, and fostering innovation in pharmaceutical education and practice, supporting the next generation of scientists and healthcare professionals.

Athiya Azeem is the Lead Product Engineer at a University of Sydney spin-out company, ASK Scientia Pty Ltd, developing innovative in vitro testing solutions for inhaled drug products. She recently completed her PhD in the fluid mechanics of dry powder inhalers, where her research focused on understanding mechanisms that drive dispersion and performance. The work she is presenting is drawn from her PhD thesis.

Athiya Azeem is the Lead Product Engineer at a University of Sydney spin-out company, ASK Scientia Pty Ltd, developing innovative in vitro testing solutions for inhaled drug products. She recently completed her PhD in the fluid mechanics of dry powder inhalers, where her research focused on understanding mechanisms that drive dispersion and performance. The work she is presenting is drawn from her PhD thesis.

I am a master’s student conducting research on the development of innovative pharmaceutical formulations using 3D printing technology. I am also working on strategies to enhance the solubility and bioavailability of poorly water-soluble drugs. Through this research, I aim to contribute to the advancement of personalized drug delivery systems and improve therapeutic outcomes by integrating formulation science with emerging manufacturing technologies.

Seungyeob Baeg is currently pursuing a Master's degree in the College of Pharmacy at Kyungpook National University, majoring in Industrial Pharmacy. His current research focuses on the development of advanced drug delivery systems utilizing 3D printing technology and the solubilization of poorly water-soluble drugs. In particular, he is deeply interested in applying a Quality by Design (QbD) approach to the solubilization process to achieve more efficient formulation development. During his undergraduate studies, he majored in pharmaceutical engineering, building a solid foundation in pharmaceutical sciences.

Xinyu Cai is a third-year PhD student in the School of Engineering at Macquarie University, Australia. Her research focuses on aerosol drug delivery with an emphasis on understanding particle transport and deposition in the human upper and lower airways. Her work integrates both computational and experimental approaches, including computational fluid dynamics (CFD), laser-based techniques such as particle image velocimetry (PIV), and model-based validation methods using 3D-printed airway replicas. Xinyu’s research aims to enhance the efficiency and targeting of inhalation therapies by improving the predictive capabilities of airway deposition models. She has authored multiple peer-reviewed journal articles in leading biomedical engineering and pharmaceutical science journals. With a strong interest in translational research and interdisciplinary collaboration, she is passionate about advancing drug delivery technologies to improve respiratory health outcomes.

Ella Cassin is a Medical Science Honours student, working with the Lambert Initiative to aid in the model validation of sleep in zebrafish for the screening of novel cannabis-derived compounds in the sleep model.

Damaranie Dipahayu was born in Surabaya on 03 March 1983. She is an assistant professor at the Republic of Indonesia Defense University. Her specialty is technology formulation in pharmacy. She has a linear research track record,which is about the potential of purple sweet potato Antin 3 variety leaves as an antioxidant and sunscreen.

Ayuka Ebisawa is a first-year Ph.D. student at the Laboratory of Advanced Drug Development Sciences, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences. Her research focuses on the development and characterization of human immortalized cell-based blood-brain barrier (BBB) spheroid models for studying brain vascular inflammation. She has presented her work at four national and international conferences. Her research interests include neuroinflammation, the blood-brain barrier, and in vitro modeling for drug screening. She aims to contribute to the advancement of therapeutic strategies for central nervous system disorders.

Professor Dewi Melani Hariyadi, SSi, MPhil, PhD, Apt is a Professor at Pharmaceutical Sciences Department, Faculty of Pharmacy Universitas Airlangga, Surabaya Indonesia. She graduated with a PhD in Pharmaceutics from The University of Queensland Australia in 2012. She has background in pharmaceutics field. Her research focuses on development of oral, inhalation and topical drug and cosmetic delivery systems. She has published 96 papers, 10 books and 4 patents in the last 10 years and scopus H-Index of 11. She is member of pharmacist association, member of vaccine consortium groups, nasal and inhalation expert forum, collegium of pharmacy Indonesia and in the past she was member of Controlled Release Society. She is also reviewers of many prestigious journals and book editor.

Angus is a doctoral candidate in the School of Pharmacy and Pharmaceutical Sciences at the University of Queensland. His research focuses on pharmaceutical formulation design in 3D printing. Specialising in Selective Laser Sintering and bioceramics his research intends to broaden the number of medication able to be 3D printed and the scope of use for SLS 3D printing. Angus is hospital clinical pharmacist currently working in the areas cardiology and cardiothoracic surgery at the Princess Alexandra Hospital in Brisbane. With over 9 years of clinical practice experience in Queensland Health Hospital and Health Services, he has practiced as as clinician pharmacist across the spectrum of clinical specialities and across inpatient, subacute and outpatient services.

Fatemeh Heidari is a PhD candidate in the Faculty of Science at the University of Technology Sydney (UTS), conducting translational research in pregnancy complications with a focus on preeclampsia. Her doctoral project investigates the therapeutic potential of nanoparticle-mediated gene delivery using RALA-sFlt1 formulations in a mouse model of preeclampsia. Fatemeh has a multidisciplinary background in molecular biology, drug delivery, and reproductive health, and collaborates with international partners, including Queen’s University Belfast. Her work integrates advanced in vivo models, echocardiography, and molecular profiling to evaluate cardiovascular, placental, and fetal outcomes, with the aim of identifying targeted and non-viral interventions for preeclampsia. Through her research, Fatemeh aims to contribute to the development of innovative and clinically relevant strategies to prevent and manage preeclampsia, ultimately improving maternal and fetal health outcomes.

Dr. Kenjirou Higashi obtained his BS and MS degrees in Pharmaceutical Sciences from Chiba University, Japan in 2004 and 2006, respectively. He started his academic carrier as an assistant professor in Department of Pharmaceutical Technology, Graduate School of Pharmaceutical Sciences, Chiba University. He got a Ph.D. degree in 2011 from Chiba University. He joined in a Prof. Ramamoorthy’ laboratory in Biophysics Department, The University of Michigan, USA as a research fellow from 2012 to 2013. He was promoted to associate professor in Chiba University in 2014. The number of the publications is more than 100 papers (h-index; 38, the number of citations; 3888). His research focuses on the specialized solid formulations to improve the solubility of poorly water-soluble drugs. So far, he has developed the techniques to prepare solid dispersion and drug nanoparticles. He is also interested in developing evaluation methods for such solid formulations, especially in solid state NMR.

Dr. Hoang Quynh Hoa is a researcher and lecturer at Hanoi University of Pharmacy (HUP), specializing in botany and medicinal plant research. With over 20 years of experience in academic teaching and scientific research, Dr. Hoa has led and contributed to numerous national and international research projects focused on botanical and traditional medicine, phytochemistry, and medicinal plant resource. Their work bridges traditional knowledge and modern science, aiming to uncover novel therapeutic agents from natural resources. Dr. Hoa has authored and co-authored several peer-reviewed publications and actively participates in professional conferences and collaborative networks. Passionate about advancing evidence-based practices, they are committed to mentoring young scientists and promoting interdisciplinary approaches in research. Dr. Hoa currently serves as Head of Botany Department, Faculty of Pharmacognosy and Traditional Pharmacy of HUP, and continues to contribute to the scientific community through both research and education.

Dr. Hoang Oanh Hua is a lecturer at the Faculty of Traditional Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. She earned her Ph.D. with a specialization in herbalism and continues to deepen her expertise in traditional Vietnamese medicine. Her research primarily focuses on materia medica and the pharmacology of natural products, with a particular interest in assessing the therapeutic efficacy of traditional herbal formulations. Driven by a passion for integrating traditional wisdom with modern scientific methods, Dr. Hua actively contributes to both academic instruction and research initiatives. Her work aims to preserve, validate, and promote the clinical use of Vietnamese medicinal plants. In addition to her research, Dr. Hua mentors students in experimental pharmacology and research methodology, nurturing future professionals in the field of traditional medicine. Her efforts highlight the importance of applying evidence-based science to enhance and support traditional healing practices.

Assoc. Prof. Dr. Kampanart Huanbutta is a distinguished pharmaceutical scientist and educator, currently serving as a university lecturer at the College of Pharmacy, Rangsit University, Thailand, and Secretary-General of the Pharmaceutical Association of Thailand under Royal Patronage. He earned his Ph.D. in Pharmaceutical Technology from Silpakorn University, supported by the Royal Golden Jubilee Ph.D. Program, and completed postdoctoral research at the University of Porto under the Erasmus Mundus grant. Dr. Huanbutta’s research specializes in advanced drug delivery systems, including 3D-printed dosage forms, nanotechnology, and pediatric and geriatric formulation design. He has received multiple accolades, such as the Outstanding Researcher Award (Rangsit University, 2024). With over 70 peer-reviewed publications and editorial roles in respected journals, his work bridges academic excellence and pharmaceutical innovation. Dr. Huanbutta is actively involved in national and international pharmaceutical organizations and continues to shape the future of drug delivery science.

She graduated from Tongji Medical University in 1996, and obtained the master's and doctor's degrees in Tongji Medical College of HUST in 2002 and 2007 respectively. In 2013, she visited the Reproductive Biology Laboratory of Stanford University Medical College and studied for one year. She has participated in the compilation of many reproductive books and published more than 60 articles and more than 30 SCI articles. Research direction: basic research is mainly engaged in reproductive and epididymal immunity, epididymal sperm maturation, egg maturation and fertilization. Clinical treatment mainly includes recurrent abortion, multiple transplantation failure, infertility, assisted reproductive technology and other related treatment.

Huiping Huang obtained her Bachelor of Medical Science from Flinders University and her Master of Philosophy in Chemical Engineering from the University of Adelaide. She has received her PhD at Sydney Pharmacy School, University of Sydney. She is currently a postdoctoral researcher in the research group of her PhD supervisor, Hien Duong. Her research focuses on biocompatible nanomaterials for biomedical applications, specifically targeting the treatment of infectious diseases.

Her name is Linyu Huang. She completed her bachelor's and master's degrees at Soochow University in China and is currently pursuing a Ph.D. at the College of Pharmacy, Yeungnam University in South Korea. Her major is pharmacy, and she has finished her first year of the doctoral program.

Minju Hyeon is a graduate student in the PKPD Laboratory at the School of Pharmacy, Sungkyunkwan University, South Korea. Her research focuses on bioanalysis and pharmacokinetics of therapeutic peptides, with an emphasis on LC–MS/MS method development and preclinical pharmacokinetic studies.

Takuro Ishinabe is a PhD student in the Department of Pharmacy at Keio University. His research focuses on developing in vitro models of the placental barrier to investigate drug transport mechanisms and assess fetal exposure risks during pregnancy. He has presented his findings at national conferences and has established RNA sequencing pipelines in his laboratory. Currently, he is initiating single-cell transcriptomic analyses to further elucidate the cellular mechanisms involved in placental barrier development. With a strong interest in both statistics and biology, as well as a passion for education, he aspires to become a researcher and educator capable of conducting cross-disciplinary research that bridges these fields.

Dr Md Khairul Islam is a researcher at the Centre for Optimisation of Medicines, The University of Western Australia. His work focuses on establishing and developing an analytical laboratory for drug content and stability studies. With a background in pharmaceutical sciences and laboratory analysis, he specialises in evaluating the drug potency and shelf-life of therapeutic products. His expertise includes analytical techniques such as HPLC, HPTLC, UV-Vis spectrophotometry, and titration, which he uses to assess drug potency, degradation, and stability under various conditions. His research supports the safe and effective use of medicines by providing critical data for quality assurance and regulatory compliance. His contributions aid in improving pharmaceutical practices and promoting patient safety through evidence-based analysis.

Dr Md Khairul Islam is a researcher at the Centre for Optimisation of Medicines, The University of Western Australia. His work focuses on establishing and developing an analytical laboratory for drug content and stability studies. With a background in pharmaceutical sciences and laboratory analysis, he specialises in evaluating the drug potency and shelf-life of therapeutic products. His expertise includes analytical techniques such as HPLC, HPTLC, UV-Vis spectrophotometry, and titration, which he uses to assess drug potency, degradation, and stability under various conditions. His research supports the safe and effective use of medicines by providing critical data for quality assurance and regulatory compliance. His contributions aid in improving pharmaceutical practices and promoting patient safety through evidence-based analysis.

Kazunori Iwanaga is a professor of Education and Research Center for Clinical Pharmacy at Osaka Medical and Pharmaceutical university. His work focuses specifically on avoiding drug-drug or drug-food/drink interaction using formulations.

Jieun Jeong is a graduate student in the Department of Pharmacy at Duksung Women’s University in Seoul, South Korea. Her research focuses on the development of drug delivery systems for central nervous system diseases, with a particular interest in nose-to-brain delivery using spray-dried porous particles. She has practical experience in formulation design, quality-by-design (QbD) based process optimization, and nanoparticle characterization. She recently submitted a review article on the intranasal delivery of donepezil to Pharmaceutics (MDPI). At AFPS 2025, she will present her recent study on the intranasal administration of sumatriptan using spray-dried mannitol-based porous carriers. Her research interests include the transdermal delivery of biologics and nucleic acid-based therapeutics, especially via the follicular route.

Ji-su Jeong is a Ph.D. student at the College of Pharmacy, Pusan National University. Her research focuses on the physicochemical properties and stability of drug substances, with particular interest in formulation development, optimization, and drug delivery systems based on drug–excipient interactions.

Mayu Kajino is a fourth-year in PhD student in World-leading Innovative & Smart Education program at the Kanazawa University . She received a bachelor’s degree in pharmacy from Kanazawa University. Her research focuses on the effects of maternal drug administration during pregnancy on offspring health, with particular emphasis on neonatal glucose metabolism. She utilizes rodent models to investigate how perinatal exposure to medications can alter glucose homeostasis in neonates. She has extensive experience in quantitative and qualitative metabolomics using LC-MS/MS. She is passionate about bridging basic science with clinical relevance in the field of perinatal and developmental medicine.

Namrah Khan; is a PhD candidate at Chungnam National University, South Korea, specializing in drug delivery and nano-therapeutics. Her research focuses on developing advanced nanoparticle-based drug delivery systems to enhance therapeutic efficacy, optimize bioavailability, and overcome physiological barriers. With a strong foundation in pharmaceutical sciences and nanotechnology, she is committed to pioneering innovative strategies for precision medicine applications. Throughout her academic career, Namrah has contributed to interdisciplinary research on lipid nanoparticles, liposomes, and targeted nano-carriers for controlled drug release. Her work has been presented at international conferences and published in peer-reviewed journals, demonstrating a dedication to advancing nanomedicine. In addition to research, Namrah actively engages in collaborative initiatives, fostering knowledge exchange within the scientific community. Her long-term goal is to pave ways for gene therapy focused nano-deliveries and bridging laboratory discoveries with clinical applications, translating nanotherapeutic innovations into viable treatments that address complex healthcare challenges.

Beomsu Kim is an integrated MS-PhD student in the Applied Nanomedicine Lab at the College of Pharmacy, Yeungnam University. The focus of his research is on designing RNA delivery systems optimized for each payload.

2017-2023: Bachelor of Science, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (Biopharmaceutics Lab) 2023-present: Ph. D. student, Graduate School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (Biopharmaceutics Lab) 2023-present: JST SPRING Scholarship Awardee

Ms. Quynh Nguyen Nhu Le is currently an undergraduate student at the School Of Pharmacy - University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. She has been actively involved in scientific research since her second year under the guidance of Assoc. Prof. Dr. Phuong Thuy Viet Nguyen. Her main research interests include molecular docking, molecular dynamics simulations, and physiologically based pharmacokinetic (PBPK) modeling, especially in antiviral drug repurposing. She has presented her team’s research at national conferences hosted by the School of Pharmacy – University of Medicine and Pharmacy at Ho Chi Minh City, focusing on HPV-related topics. Internationally, she presented a study on non-alcoholic fatty liver disease (NAFLD) at AFPS 2023 and research on potential inhibitors targeting the NS4B protein of DENV-2 at ASEANPharmNET 2024. In the future, she plans to pursue graduate studies in computational pharmacology and develop effective therapies through in silico methods.

Lee Yeon-sil is a Ph.D. candidate in Pharmaceutics in the Department of Pharmacy (College of Pharmacy), Duksung Women’s University, South Korea. She earned her master’s degree in Pharmaceutics from the same department and is currently a member of the Pharmaceutical Research Laboratory (PRL), where she focuses on the development of inhalation formulations. Her research centers on the formulation development and optimization of lyotropic liquid crystal nanoparticles (LCNPs) for intranasal brain delivery of therapeutic agents targeting neurodegenerative diseases. During her graduate studies, she gained expertise in formulation optimization using a Design of Experiments (DoE) approach, nanostructure characterization via small-angle X-ray scattering (SAXS), and drug permeability assessment using PAMPA and nasal epithelial cell models. She is currently conducting research to enhance brain drug delivery by designing hexosome formulations with improved stability, permeability, and sustained-release characteristics.

Dr Loo received her PhD from University of Sydney with research focus in microbial biofilm and nanomedicine.

Associate Professor School of Pharmacy, University of Otago, New Zealand and an Honorary Professor at Chengdu University of Traditional Chinese Medicine in China. Research interests are polymeric nanomedicines for oral delivery of proteins and peptides and understanding interactions at the nano-bio interrface. Arlene also works at the emerging intersection of pharmaceutical science and wildlife therapeutics. She has held leadership positions in the Controlled Release Society including Chair of the Veterinary Committee, President of the New Zealand Chapter of CRS and Editor-in-Chief of the CRS Newsletter and recently served on the Board of the Australasian Colloid and Interface Society and is an Editor for the European Journal of Pharmaceutics and Biopharmaceutics. McDowell is a strong advocate for education and has won prizes for both excellence and innovation in undergraduate teaching and is Director of the new Bachelor of Pharmaceutical Science degree launched at the University of Otago in 2022.

Taye Tolu Mekonnen is a postdoctoral research associate at the University of Sydney. He received his PhD in Biomedical Engineering from Macquarie University in 2020, where his notable contribution was the development of a pioneering optical technology for high-speed imaging in inhalation drug delivery systems and rapid non-destructive industrial testing. Furthermore, Mekonnen completed his MSc in Computer Engineering at Addis Ababa University and a BSc in Electrical Engineering at Bahir Dar University, both in Ethiopia. Following his PhD, he pursued postdoctoral research at the University of Houston, USA, where he introduced a novel reverberant optical coherence elastography (OCE) technique to characterize biomechanical properties of tissues. His ongoing research is focused on developing a high-resolution optical coherence tomography (OCT) technique to assess the dynamic behaviour of dry powders, including their deposition and dissolution characteristics, relevant to inhalation drug delivery.

Miseon Na is an Integrated MS/PhD student in the Department of Pharmaceutical Analysis at Duksung Women’s University, Republic of Korea. Her research centers on pharmaceutical particle engineering, with a focus on micronization techniques such as jet milling. She investigates how process parameters influence particle size distribution, morphology, and physicochemical properties of active pharmaceutical ingredients. Her experimental work includes solid-state characterization using techniques such as laser diffraction, scanning electron microscopy (SEM), and differential scanning calorimetry (DSC). In addition to her primary work on jet milling, she has academic experience in real-time analytical approaches and quality control. She is particularly interested in the application of process optimization to enhance formulation performance and drug delivery. Miseon is an enthusiastic researcher with a growing record of scientific presentations and a strong commitment to innovation in pharmaceutical manufacturing.

Bao Loc Nguyen is a postdoctoral researcher in the Kim Laboratory, College of Pharmacy, Yeungnam University. He is PhD (2024) in Pharmaceutical Science. In his PhD time, he designed and fabricated nanomedicines to enhance cancer immunotherapy. Now, he is focusing on the delivery system for nucleic acid-based materials.

Nguyen Hoang Anh Kiet is a recent graduate from the Department of Pharmaceutical Informatics, School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam. His academic interests focus on computational drug discovery, siRNA design, and molecular dynamics simulations. During his undergraduate research, he applied a wide range of in silico tools to identify and evaluate potential siRNA therapeutics for hepatocellular carcinoma. He has hands-on experience with molecular docking, PPI network analysis, and 3D structural modeling using software such as AutoDock, GROMACS, and Cytoscape. Kiet is passionate about integrating bioinformatics and artificial intelligence in pharmaceutical sciences to accelerate the discovery of targeted therapies. He aims to pursue further research in molecular modeling and personalized medicine. He is currently presenting this work at AFPS 2025 to share his findings and gain valuable feedback from international researchers in the pharmaceutical field.

Nguyen Hoang Anh Kiet is a graduate from the Department of Pharmaceutical Informatics, School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam. His research interests focus on in silico drug discovery, including pharmacophore modeling, molecular docking, and molecular dynamics simulations. As part of his undergraduate thesis, he explored natural compounds from the Apiaceae family as potential inhibitors of the MTAN enzyme in Helicobacter pylori. He utilized tools such as MOE and GROMACS to evaluate compound binding affinity, stability, and drug-likeness. He is passionate about computer-aided drug design and the application of natural products in antimicrobial research. Kiet plans to pursue further studies in pharmaceutical sciences and contribute to plant-based drug development.

Nguyen Ngoc Ha Phuong is currently pursuing Master’s degree at the College of Pharmacy, Chungnam National University, Republic of Korea. She earned Pharmacist degree from Hanoi University of Pharmacy, Vietnam. With a strong academic background in pharmaceutical sciences, her current research focuses on the design and evaluation of pharmaceutical nanocarrier systems, particularly in the field of nanostructured drug delivery for poorly water-soluble drugs. She is particularly interested in novel formulation strategies that enhance oral bioavailability and therapeutic efficacy.

Bao Anh Nguyen earned a Bachelor of Pharmacy degree from Ton Duc Thang University in Vietnam before pursuing graduate studies at the College of Pharmacy, Chungnam National University, South Korea. With a solid foundation in pharmaceutical sciences, he is currently focusing on research in solid dosage formulations, particularly the physicochemical properties of active pharmaceutical ingredients (APIs) and their impact on bioavailability.

Nguyen Quoc Binh is currently an undergraduate student of the DCQ 2022 cohort at Ho Chi Minh City University of Pharmacy, under the University of Medicine and Pharmacy at Ho Chi Minh City. He is an active member of the Social Work Club of the university and has consistently participated in various volunteer and extracurricular activities. In the previous semester, he achieved an impressive GPA of 3.21. At present, he serves as the monitor of the Department of Pharmaceutical Information Technology and is actively involved in the department’s research activities. Furthermore, he demonstrates strong presentation skills and proficiency in computer applications, which significantly support both his academic and research endeavors. Nguyen Thi Kim Tim is an enthusiastic pharmacy student at the University of Medicine and Pharmacy at Ho Chi Minh City, expected to graduate in 2025 with a GPA of 3.21/4.00. Throughout her university years, she has been highly engaged in student activities and volunteer work. She was a member of the university’s Pharmacy Association and participated in organizing events such as the International Medical Biochemistry Competition (IMBC) 2024 and the campus-wide Volunteer Blood Donation campaign. Kim Tim also took part in the “Green Campaign for Public Health” and joined the “Step for Future” campaign supporting women’s cancer treatment. In addition, she actively participated in university cheerleading and cultural events. These diverse experiences have helped her develop leadership, teamwork, and communication skills beyond the classroom. With a passion for healthcare and community service, she strives to make a positive impact in both academic and social settings.

apt. Fahrul Nizar Novagusda, M.Farm. is a lecturer in Industrial Pharmacy at the Faculty of Pharmacy, Universitas Pertahanan Republik Indonesia (Indonesian Defense University). Born in Semarang on November 13, 1987, he earned both his Bachelor's and Master's degrees in Pharmacy from Universitas Pancasila. His academic work focuses on pharmaceutical production systems, quality assurance, and the downstream development of research-based products. In addition to teaching, he actively contributes to academic curriculum development and organizes scientific seminars aimed at bridging academia, industry, and regulatory bodies. His research interests include pharmaceutical formulation, the influence of halal labeling on consumer purchasing behavior, and the utilization of natural ingredients in healthcare products. Known for his commitment to advancing pharmaceutical education and national self-reliance, Fahrul is also engaged in capacity-building efforts within the military pharmacy sector and advocates for collaboration to strengthen Indonesia’s pharmaceutical resilience.

Rika Onishi is a graduate student at the Graduate School of Pharmaceutical Sciences, Osaka University, Japan, specializing in vaccine research and drug delivery technologies. Her work focuses on developing adenoviral vector-based vaccine platforms by engineering viral capsid components to enhance gene delivery efficiency and immunogenicity. In her previous research on adenovirus serotype 35 (Ad35) vector vaccines, she developed a novel Ad35 vaccine candidate incorporating an RGD peptide in the fiber knob and insertion of E4 orf 4, 6, and 6/7 regions of Ad5 (Onishi R., et al., Int. J. Pharm., 2024). She is currently investigating how cellular entry pathways of adenoviral vectors affect vaccine efficacy. By elucidating the relationship between vector internalization routes and immune activation, her studies aim to provide a rational foundation for next-generation adenoviral vaccine design. Her dedication to innovative pharmaceutical sciences continues to drive her exploration of cutting-edge biotechnologies.

Jin Woo Park is a master's student in the College of Pharmacy at Inje University, Republic of Korea, under the supervision of Professor Kwan Hyung Cho. He earned his bachelor's degree in pharmaceutical engineering from the same university, graduating with distinction. His research focuses on drug solubilization, stabilization, and formulation development, particularly for poorly soluble compounds. He has authored publications in leading journals such as Molecules, Pharmaceutics, and Gels, highlighting innovative work on supersaturated formulations and gastroretentive drug delivery systems. His current interests include the design of incrementally modified drugs, the application of physicochemical principles in drug repositioning, and advanced formulation strategies such as SNEDDS and sustained-release systems.

Jin Woo Park is a master's student in the College of Pharmacy at Inje University, Republic of Korea, under the supervision of Professor Kwan Hyung Cho. He earned his bachelor's degree in pharmaceutical engineering from the same university, graduating with distinction. His research focuses on drug solubilization, stabilization, and formulation development, particularly for poorly soluble compounds. He has authored publications in leading journals such as Molecules, Pharmaceutics, and Gels, highlighting innovative work on supersaturated formulations and gastroretentive drug delivery systems. His current interests include the design of incrementally modified drugs, the application of physicochemical principles in drug repositioning, and advanced formulation strategies such as SNEDDS and sustained-release systems.

She is a Master’s student in the Department of Pharmaceutical Sciences, specializing in industrial pharmacy and transdermal drug delivery systems. Her research is dedicated to developing dissolving microneedles incorporating solubilized econazole nitrate, specifically to overcome the solubility-limited skin permeability of this antifungal agent. By enhancing econazole’s solubility and optimizing microneedle fabrication using hydrophilic polymers, her work aims to significantly improve transdermal absorption and therapeutic efficacy, ultimately contributing to more patient-centric antifungal therapies. With a strong passion for translating fundamental research into clinically viable drug delivery platforms, she is also deeply committed to interdisciplinary collaboration within pharmaceutical sciences. Through participation in AFPS 2025, she seeks to deepen her understanding of emerging drug delivery technologies, foster valuable knowledge exchange, and make impactful contributions to the field's advancement through data-driven and application-oriented research.

My name is Hyunjong Park, and I am currently pursuing a Master’s degree at Kyungpook National University in South Korea. My primary research focuses on the solubilization of poorly water-soluble drugs and the development of drug delivery systems utilizing 3D printing technology. Presently, I am engaged in the development of drug delivery platforms that integrate both drug solubilization and dosage form fabrication into a single process.

Susmita Paul is a PhD student at the School of Allied Health at the University of Western Australia. She completed her bachelor’s and master’s degrees in pharmacy from Khulna University, Bangladesh. Susmita has research interests within the fields of pharmaceutics and formulation development. Previously she worked on medicinal formulation development using natural products at her home university. Susmita’s PhD project at UWA is to review, develop and evaluate strategies to taste mask unpalatable paediatric medicines. Prof. Lee Yong Lim, A/Prof. Connie Locher, and Dr. Okhee Yoo are her PhD project supervisors.

Tesia Aisyah Rahmania was born in Yogyakarta on January 4, 1994. She is a Lecturer in Pharmaceutical Chemistry at the Faculty of Military Pharmacy, Republic of Indonesia Defense University (Universitas Pertahanan RI), located in Sentul, Bogor. She earned her Bachelor's degree in Chemistry from Yogyakarta State University in 2016 and her Master's in Pharmaceutical Sciences from Universitas Gadjah Mada in 2020. Her research focuses on synthesizing organic compounds as potential drug candidates and evaluating their biological activity. She has published 20 articles in reputable national and international journals indexed by Scopus and SINTA (Scopus ID: 57216224997; H-index: 3; Citations: 30).

Moumita Saha is ICMR Project Scientist -I(non medical) pursuing PhD at the Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India. Her research interest is in the field of formulation development for Helicobacter pylori infection and associated gastric complications like gastric ulcer, gastric cancer.She holds an M. Pharm in Pharmaceutical Analysis from ISF college of Pharmacy, Punjab and a B. Pharm from Bengal School of Technology, West Bengal. With multiple peer-reviewed publications in reputed journals and a strong background in pharmaceutical analysis, drug delivery, and biopharmaceutics. She has presented her research at international conferences and completed specialized training in drug metabolism, pharmacokinetics, and research ethics

Education M.S. Graduate School of Pharmaceutical Sciences, University of Shizuoka B.S. School of Pharmaceutical Sciences, University of Shizuoka Academic degree Ph.D. Graduate School of Pharmaceutical Sciences, University of Shizuoka Career 2005.9 - 2014.3 University of Shizuoka, School of Pharmaceutical Sciences, Research Associate 2014.4 - 2016.9 University of Shizuoka, School of Pharmaceutical Sciences, Assistant Professor 2016.10 - 2024.3 Hamamatsu University School of Medicine, Preeminent Medical Photonics Education & Research Center, Associate Professor 2024.4 - Present Hamamatsu University School of Medicine, Institute of Photonics Medicine, Nanotheranostics Laboratory, Associate Professor, Principal Investigator Research fields Targeted nano-drug delivery and therapy Optical imaging diagnosis and therapy

May Song, a doctor specializing in pharmaceutics, has extensive experience in researching and developing conventional and novel drug delivery systems. Her specialist interests revolve around pioneering pharmaceutical technologies, innovative drug dosage forms, and the evaluation of formulations in both in vitro & in vivo performance. She has successfully completed various projects, such as drug-controlled release systems, long-acting injections, cutting-edge taste-masking techniques for oral medications, and oral drug delivery systems aimed at enhancing bioavailability and drug stability. At the University of South Australia, she is actively engaged in multiple projects conducted at the Centre for Pharmaceutical Innovation, which houses state-of-the-art pilot-scale pharmaceutical manufacturing facilities. She offers consultancy services to the industry, leads research and development initiatives, and mentors undergraduate and postgraduate students. Furthermore, she possesses extensive expertise in the management of a pharmaceutical laboratory.

May Song, a doctor specializing in pharmaceutics, has extensive experience in researching and developing conventional and novel drug delivery systems. Her specialist interests revolve around pioneering pharmaceutical technologies, innovative drug dosage forms, and the evaluation of formulations in both in vitro & in vivo performance. She has successfully completed various projects, such as drug-controlled release systems, long-acting injections, cutting-edge taste-masking techniques for oral medications, and oral drug delivery systems aimed at enhancing bioavailability and drug stability. At the University of South Australia, she is actively engaged in multiple projects conducted at the Centre for Pharmaceutical Innovation, which houses state-of-the-art pilot-scale pharmaceutical manufacturing facilities. She offers consultancy services to the industry, leads research and development initiatives, and mentors undergraduate and postgraduate students. Furthermore, she possesses extensive expertise in the management of a pharmaceutical laboratory.

Yunita Suffiana is a pharmacist with a master's degree in clinical pharmacy. She has been working as a clinical pharmacist since 2017 at Dr. Zainoel Abidin Public Hospital in Banda Aceh, Indonesia. She has specialized in pediatric pharmacy since 2019 and continues to focus on this field. Currently, she is responsible for pediatric medication management, ensuring optimal therapeutic outcomes for young patients, and compounding parenteral electrolyte nutrition for pediatric patients as prescribed by doctors. Yunita is also actively involved in hospital research and academic collaborations, mentoring undergraduate students and serving as a clinical preceptor. Additionally, she was a speaker at the 2024 National Annual Scientific Week of the Hospital Pharmacy Association in Semarang,where she presented a case study on antibiotic therapy monitoring in pediatric patients with a focus on pharmacokinetics/pharmacodynamics. She is committed to advancing pharmaceutical care for children and continuously explores innovative approaches to improve medication safety and efficacy.

Sumarheni is currently a Higher Degree by Research (HDR) student at the School of Pharmacy, University of Sydney, based at Westmead Hospital. Her research focuses on the optimisation of pharmaceutical interventions in tuberculosis and respiratory virus co-infection. She holds a Master’s degree in Pharmacy from the University of Barcelona and the University of Joseph Fourier (now University of Grenoble), and has extensive academic experience as a lecturer at Hasanuddin University, Makassar, Indonesia. Her clinical background includes clinical laboratory services, and she has contributed to multiple community-based health programs. She is also actively involved in educational outreach and interprofessional health training. Her current work aims to strengthen the evidence base for pharmacist-led interventions in infectious disease settings, combining research, clinical practice, and public health impact. She aspires to contribute to global TB elimination efforts through interdisciplinary pharmaceutical research.

Srija Sur is a PhD student at the University of Sydney working under the primary supervision of Dr. Pegah Varamini. In December 2022, she received the Research Training Program (RTP) tuition fee offset and stipend Commonwealth Government Scholarship (International) to pursue her PhD from Australia. She holds a post-graduate degree in pharmaceutical science, specializing in Pharmaceutics. Driven by her passion for research, she is committed to developing targeted formulations for the diagnosis and treatment of cancer. Beyond her research, she is enthusiastic about gaining new skills through diverse activities such as chairing committees and organizing workshops, fostering both personal and professional growth. Furthermore, she has over two years of experience as an Assistant Professor overseas.

Chetna Suyal is currently pursuing her PhD at Manipal College of Pharmaceutical Sciences (MCOPS), Manipal Academy of Higher Education, Manipal, Karnataka, India. Her research is centered on computational drug discovery with a special focus on targeting oncogenic mutations in cancer using natural compounds. She has a strong background in molecular modeling, virtual screening, and ADMET prediction, with specific expertise in the in-silico evaluation of phytochemicals such as quercetin derivatives. Her recent work involves the use of structure-based drug design techniques to identify potential inhibitors of the KRASG12D mutation against pancreatic cancer. She has participated in multiple national and international conferences.

Dr. Waiting Tai is a postdoctoral research associate in the Advanced Drug Delivery Group at the Sydney Pharmacy School, The University of Sydney. He received his Bachelor of Pharmacy with First Class Honours from the same institution and was on the Dean’s list for excellent academic performance in 2019. He completed his PhD in 2024, focusing on the development of novel inhalable cannabidiol formulations. Dr. Tai’s research specialises in pulmonary drug delivery, with expertise in the engineering and physicochemical characterisation of pharmaceutical aerosol formulations. He has authored over 10 peer-reviewed publications and collaborates with academic and industry partners both locally and internationally on formulation and interdisciplinary projects.

Miss Tang Qinghan, PhD in traditional Chinese medicine at Nanjing University of Traditional Chinese Medicine，Nanjing，RP China.She is engaged in the research of traditional Chinese medicine delivery system for the treatment of chronic wounds and hypertrophic scars, covering preparations and biomaterials such as microneedles, liposomes, gel, etc. She has published a total of 7 SCI papers, among which the first author/co first author has published papers in journals such as Advanced Drug Delivery Review, Journal of Controlled Release, Burns&Trauma, etc

She graduated with a degree in Pharmacy from the University of Medicine and Pharmacy in Ho Chi Minh City. She is passionate about computer-aided drug design, especially elucidating the mechanisms of action of medicinal herbs in specific therapeutic contexts, and has been studying this field for two years. Her research techniques include network pharmacology, molecular docking, and molecular dynamics simulation (MDs). She would be grateful for the opportunity to learn from and engage in discussions with experts, professors, and students who share the same passion.

Catherine TULEU, Docteur en Pharmacie, PhD, is Professor in Paediatric Pharmaceutics at UCL School of Pharmacy, UK. (https://orcid.org/0000-0001-8384-357X ; H-index 40) Her research, inherently translational, ranges from formulation, methodology development to clinical implementation, integrating the following themes: children centric excipient research; repurposing by reformulating for better medicines for children; development of innovative age appropriate dosage forms (especially for under 5s); administration issues and devices and sensory pharmaceutics (dosage form acceptability and in vitro/in vivo taste assessment). https://www.ucl.ac.uk/pharmacy/people/professor-catherine-tuleu Her spin out company senCeuTics Ltd. specializes in pharmaceutical sensory evaluation and offers a full spectrum of preclinical, clinical and paediatric formulation services under one roof. https://senceutics.com/ She is the founder and chairperson of the European Paediatric Formulation Initiative (EuPFI), a consortium working in a pre-competitive way on paediatric drug formulations. http://www.eupfi.org/ https://www.linkedin.com/in/catherine-tuleu-9b842214/

Catherine TULEU, Docteur en Pharmacie, PhD, is Professor in Paediatric Pharmaceutics at UCL School of Pharmacy, UK. (https://orcid.org/0000-0001-8384-357X ; H-index 40) Her research, inherently translational, ranges from formulation, methodology development to clinical implementation, integrating the following themes: children centric excipient research; repurposing by reformulating for better medicines for children; development of innovative age appropriate dosage forms (especially for under 5s); administration issues and devices and sensory pharmaceutics (dosage form acceptability and in vitro/in vivo taste assessment). https://www.ucl.ac.uk/pharmacy/people/professor-catherine-tuleu Her spin out company senCeuTics Ltd. specializes in pharmaceutical sensory evaluation and offers a full spectrum of preclinical, clinical and paediatric formulation services under one roof. https://senceutics.com/ She is the founder and chairperson of the European Paediatric Formulation Initiative (EuPFI), a consortium working in a pre-competitive way on paediatric drug formulations. http://www.eupfi.org/ https://www.linkedin.com/in/catherine-tuleu-9b842214/

Nguyen Thanh Tu is a fifth-year pharmacy student at the University of Medicine and Pharmacy at Ho Chi Minh City. Tu has had the opportunity to participate in research related to Self-Microemulsifying Drug Delivery Systems (SMEDDS) for the past two years, with a focus on improving the solubility and bioavailability of poorly water-soluble drugs. Currently, Tu is working on a student research project in this area under academic supervision. Through this experience, Tu has gained a deeper understanding of formulation development and is gradually building practical research skills. With an interest in pharmaceutical sciences, Tu hopes to continue learning and contribute to the field, particularly in the development of more effective drug delivery systems.

Dr. Zhizhen Wang is a research fellow in Lambert Initiative for Cannabinoid Therapeutics at University of Sydney. Zhizhen received her PhD in neuroscience from the University of Wollongong in 2023. Her research focuses on the exploring the potential benefits of cannabinoids on the ageing process using the Caenorhabditis elegans (C. elegans) and human cell models. As an early career researcher, she has already authored 11 papers, with 6 as the first author, garnering a total of 685 citations in the fields of ageing and cannabis. She has co-supervised three honors students and is currently mentoring one PhD student. She also contributes as a reviewer for leading ageing journals.

I am a master’s student currently engaged in pharmaceutical research focused on the development of novel drug formulations. My work includes designing oral dosage forms such as gastroretentive and sustained-release tablets. In addition, I am conducting research on solubilization strategies for poorly water-soluble drugs to enhance their bioavailability. Through these efforts, I aim to contribute to the advancement of personalized and efficient drug delivery systems using innovative formulation technologies.

Qing Xia earned her B.S. in Pharmaceutics from Hanlin College, Nanjing University of Chinese Medicine. She is currently a third-year Master of Medicine (M.Med) candidate specializing in Pharmaceutics at Nanjing University of Chinese Medicine. Her research focuses on cell-based therapies for tissue engineering applications.

Ms.Yamaguchi is an undergraduate student at the department of Physical Pharmaceutics, Kumamoto University, majoring in pharmaceutical sciences. In the current study, she is evaluating the effect of salt-loading on the progression of chronic kidney disease (CKD) in CKD mice, which is an irreversible condition and in which excessive salt intake exacerbates renal fibrosis and tubular damage, especially in patients with CKD, increasing the risk of renal function decline and end-stage renal failure. In particular, excessive salt intake in CKD patients increases the risk of renal function decline and end-stage renal failure. She hopes that by reducing the progression of CKD pathology caused by excessive salt intake, the number of patients forced to undergo dialysis will decrease. In the future, she hopes to use the knowledge and experience she gained from this study to contribute to society as a researcher.

Ru Yan is a Professor in the State Key Laboratory of Quality Research in Chinese Medicine & the Institute of Chinese Medical Sciences at University of Macau, deputy director of Macao Centre for Research and Development in Chinese Medicine, member of the Expert Advisory Committee for the Evaluation of Chinese Proprietary Medicines in Macao SAR. Her current research focuses on the host-gut microbiota coordination in host metabolic homeostasis and xenobiotic elimination, specifically, the host UDP-glucuronosyltransferases (UGTs) - gut microbial β-glucuronidases (GUSs) axis and glucuronidation homeostasis, aiming to promote mechanistic understanding, early diagnosis, precision medicine and herbal medicine innovation for diseases such as colorectal cancer. Dr. Yan’s research has attracted over 20 external/internal research grants and over 100 peer-reviewed research articles have been published in prestigious journals in drug metabolism, analytical chemistry, ethnopharmacology and microbiology, such as Anal Chem, Nat Commun, Drug Metab Dispos, J Autoimmun, Microbiome, Biochem Pharmacol, etc.

formulation and pharmacokinetic (PK) analysis. Her PhD at UWA focused on children's oral medications, involving population PK analysis and formulation. This experience led to her role as a Senior Research Officer, conducting pharmacometric analyses and dose optimisation for clinical trials. Dr. Yoo has since spearheaded innovative projects like preprocedural tablets and a high-dose anti-infective paediatric oral delivery platform. Her expertise in experimental design has also enhanced numerous collaborative projects. A dynamic and adaptable researcher, Dr. Yoo actively fosters interdisciplinary partnerships, significantly contributing to evidence-based, patient-centred therapeutics in WA through collaborations with leading researchers.

Dr. Okhee Yoo, an Early- and Mid-Career Research Fellow in Pharmacy at The University of Western Australia, specialises in paediatric formulation and pharmacokinetic (PK) analysis. Her PhD at UWA focused on children's oral medications, involving population PK analysis and formulation. This experience led to her role as a Senior Research Officer, conducting pharmacometric analyses and dose optimisation for clinical trials. Dr. Yoo has since spearheaded innovative projects like preprocedural tablets and a high-dose anti-infective paediatric oral delivery platform. Her expertise in experimental design has also enhanced numerous collaborative projects. A dynamic and adaptable researcher, Dr. Yoo actively fosters interdisciplinary partnerships, significantly contributing to evidence-based, patient-centred therapeutics in WA through collaborations with leading researchers.

Dr. Yu is currently the Associate Professor of the Institute of Chinese Medical Sciences, State Key Laboratory of Mechanism and Quality of Chinese Medicine, University of Macau. He earned his PhD degree in Biomedical Sciences from the University of Macau. His research interests focus on innovative pharmaceutical designs of Chinese medicine, the functional polymeric nanoparticles for drug delivery, and the quality consistency assessment and the quality control standard investigation of anti-inflammatory Chinese herbal medicines. He has published over 120 peer-reviewed articles in his research fields, and with an h-index of 39 (google scholar). He is serving as the editor of Phytochemical Analysis and the section editor (Nanomedicine) of Current Pharmaceutical Design.

A/Prof. Fanfan Zhou is currently the Head of Pharmacology discipline and the Head of Molecular Drug Development Unit at the Sydney Pharmacy School, the University of Sydney. She received her PhD of Pharmaceutical Science from Rutgers, the State University of New Jersey, USA and her bachelor's degree from China Pharmaceutical University. Her laboratory research focuses on two main themes: drug discovery and development for cancers and retinal diseases as well as structure-function relationship and molecular regulation of human Solute Carrier Transporters. Her research also expands to targeted drug design, pharmacogenomics of drugs and pharmacological research on natural compounds.

Associate professor Thuan Thi Minh Nguyen obtained Master's degree in pharmacy with specialization in drug quality control - Toxicology from University of Medicine and Pharmacy at Ho Chi Minh City (UMP) in 2007. In 2015, she obtained Doctor’s degree in biomedical and pharmaceutical sciences from Université Catholique de Louvain in Brussels in Belgium. She is currently senior lecturer and deputy head of Department of Biochemistry at Faculty of Pharmacy – UMP, Ho Chi Minh City, Viet Nam. She has more than 52 publications on biochemistry, toxicology, and clinical biochemistry.